A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

ROWLEY, JANET D.·1973·Nature
DOI 10.1038/243290a0

Cited by (1,005)

Items 101–200 of 1,005

  1. Specific Targeted Therapy of Chronic Myelogenous Leukemia with Imatinib
    Michael W. Deininger, Brian J. Druker · 2003 · Pharmacological Reviews
  2. Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase
    François Guilhot, Jane F. Apperley, Dong‐Wook Kim, Eduardo Oscar Bullorsky, Michele Baccarani, Gail J. Roboz, Sergio Amadori, Cármino Antônio De Souza, Jeffrey Howard Lipton, Andreas Hochhaus et al. · 2007 · Blood
  3. Chronic Myelogenous Leukemia
    Brian J. Druker, Stephen G. O’Brien, Jörge E. Cortes, Jerald P. Radich · 2002 · Hematology
  4. New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia
    D WILLIAMS, A THOMASLOOK, S MELVIN, Paula K. Roberson, Gary Van Houten Dahl, T FLAKE, Sanford A. Stass · 1984 · Cell
  5. Alternative tumour-specific antigens
    Christof C. Smith, Sara R. Selitsky, Shengjie Chai, Paul M. Armistead, Benjamin Garrett Vincent, Jonathan Stuart Serody · 2019 · Nature reviews. Cancer
  6. The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML
    David L.P. Vetrie, G. Vignir Helgason, Mhairi Copland · 2020 · Nature reviews. Cancer
  7. BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents
    A Bedi, James P. Barber, GC Bedi, Wafik S. El‐Deiry, David Sidransky, MS Vala, AJ Akhtar, J Hilton, RJ Jones · 1995 · Blood
  8. Philadelphia ChromosomePositive Leukemias: From Basic Mechanisms to Molecular Therapeutics
    Razelle Kurzrock, Hagop M. Kantarjian, Brian J. Druker, Moshe Talpaz · 2003 · Annals of Internal Medicine
  9. Chronic Granulocytic Leukemia
    George P. Canellos · 1976 · Medical Clinics of North America
  10. Chromosomal banding patterns in acute nonlymphocytic leukemia
    JD Rowley, D Potter · 1976 · Blood
  11. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia
    Paolo Neviani, Ramasamy Santhanam, Joshua J. Oaks, Anna M. Eiring, Mario Notari, Bradley Wayne Blaser, Shujun Liu, Rossana Trotta, Natarajan Muthusamy, Carlo B Gambacorti-Passerini et al. · 2007 · Journal of Clinical Investigation
  12. Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides
    Cezary A. Szczylik, Tomasz Skórski, Nicholas C. Nicolaides, Livia Manzella, Lucia Malaguarnera, Donatella Venturelli, Alan M. Gewirtz, Bruno Calabretta · 1991 · Science
  13. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells
    Eberhard Gunsilius, Hans‐Christoph Duba, Andreas Leo Petzer, Christian M. Kähler, Kurt Grünewald, Günther Stockhammer, Christoph Gabl, Stephan Dirnhofer, Johannes Clausen, Günther A. Gastl · 2000 · The Lancet
  14. bcr‐abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.
    Andrew G. Elefanty, Iswar K. Hariharan, Suzanne Cory · 1990 · The EMBO Journal
  15. The Status of the Gene Map of the Human Chromosomes
    Victor A. McKusick, Frank H. Ruddle · 1977 · Science
  16. Clinical Significance of Cytogenetic Abnormalities in Adult Acute Lymphoblastic Leukemia
    Stefan H Faderl, Hagop M. Kantarjian, Moshe Talpaz, Zeev E. Estrov · 1998 · Blood
  17. Activation Of Cellular Oncogenes in Hemopoietic Cells by Chromosome Translocation
    Suzanne Cory · 1986 · Advances in cancer research
  18. Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance
    Alison M. Schram, Matthew T. Chang, Philip Jonsson, Alexander Edward Dela Cruz Drilon · 2017 · Nature Reviews Clinical Oncology
  19. Generation of the AML1‐EVI‐1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.
    Kinuko Mitani, Seishi Ogawa, Tetsuhiro Tanaka, Hiroyuki Miyoshi, Mineo Kurokawa, Hiroyuki Mano, Y Yazaki, M. Ohki, Hisamaru Hirai · 1994 · The EMBO Journal
  20. Oligomerization of the ABL Tyrosine Kinase by the Ets Protein TEL in Human Leukemia
    Todd R. Golub, Andrei Goga, George F. Barker, Daniel Afar, Jami McLaughlin, Stefan K. Bohlander, Janet D. Rowley, Owen N. Witte, Dwight Gary Gilliland · 1996 · Molecular and Cellular Biology
  21. Unique Forms of the abl Tyrosine Kinase Distinguish Ph 1 -Positive CML from Ph 1 -Positive ALL
    Steven S. Clark, Jami McLaughlin, WM Crist, Richard E. Champlin, Owen N. Witte · 1987 · Science
  22. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases
    Claudia Schoch, Susanne Schnittger, Sabina Bursch, Daniela Gerstner, Andreas Hochhaus, Ute Berger, Rüdiger Hehlmann, Wolfgang Hiddemann, Torsten Haferlach · 2002 · Leukemia
  23. Leukaemogenesis: more than mutant genes
    Jianjun Chen, Olatoyosi M. Odenike, Janet D. Rowley · 2009 · Nature reviews. Cancer
  24. Identification of fusion genes in breast cancer by paired-end RNA-sequencing
    Henrik Edgren, Astrid Murumägi, Sara Kangaspeska, Daniel Nicorici, Vesa Hongisto, Kristine Kleivi Sahlberg, Inga Hansine Rye, Sandra Nyberg, Maija Wolf, Anne‐Lise Børresen‐Dale et al. · 2011 · Genome biology
  25. The chronic myeloid leukemia stem cell: stemming the tide of persistence
    Tessa L. Holyoake, David L.P. Vetrie · 2017 · Blood
  26. Molecular Basis of Human B Cell Neoplasia
    Carlo Maria Croce, Peter C. Nowell̀ · 1985 · Springer eBooks
  27. BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
    Xin An, Amit Kumar Tiwari, Yibo Sun, Pei-Rong Ding, Charles R. Ashby, Zhe‐Sheng Chen · 2010 · Leukemia Research
  28. Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
    Jie He, Omar Ibrahim Abdel-Wahab, Michelle K. Nahas, Kai Wang, Raajit K. Rampal, Andrew M. Intlekofer, Jay L. Patel, Andrei V Krivstov, Garrett Michael Frampton, Lauren E. Young et al. · 2016 · Blood
  29. Integrative analysis of the melanoma transcriptome
    Berger, Michael F., Levin, Joshua Z., Vijayendran, Krishna, Sivachenko, Andrey, Adiconis, Xian, Maguire, Jared, Johnson, Laura A., Robinson, James, Verhaak, Roel G., Sougnez, Carrie et al. · 2010 · Genome Research
  30. Onco gen: Human oncogene locations and chromosome aberrations
    Janet D. Rowley · 1983 · Nature
  31. Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition
    Robert Jr. Roskoski · 2012 · Pharmacological Research
  32. Identification of the Constant Chromosome Regions Involved in Human Hematologic Malignant Disease
    Janet D. Rowley · 1982 · Science
  33. Human cytogenetics: 46 chromosomes, 46 years and counting
    Barbara J. Trask · 2002 · Nature Reviews Genetics
  34. Exon Array Profiling Detects EML4-ALK Fusion in Breast, Colorectal, and Non–Small Cell Lung Cancers
    Eva Lin, Li Li, Yinghui Guan, Robert H. Soriano, Celina Sanchez Rivers, Sankar Mohan, Ajay Pandita, Jerry Tang, Zora D. Modrusan · 2009 · Molecular Cancer Research
  35. Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities
    Jessica Plati, Octavian Bucur, Roya Khosravi‐Far · 2008 · Journal of Cellular Biochemistry
  36. Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring
    Elias Joseph Jabbour, Hagop M. Kantarjian · 2022 · American Journal of Hematology
  37. Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion
    Debyani Chakravarty, Amber Johnson, Jeffrey Sklar, Neal Ian Lindeman, Kathleen N. Moore, Shridar Ganesan, Christine Marie Lovly, Jane Perlmutter, Stacy W. Gray, Jimmy Hwang et al. · 2022 · Journal of Clinical Oncology
  38. Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV
    Alice Charlotte Fabarius, Armin Leitner, Andreas Hochhaus, Martin C. Müller, Benjamin Hanfstein, Claudia Haferlach, Gudrun Göhring, Brigitte Schlegelberger, Martine Jotterand, Andreas Reiter et al. · 2011 · Blood
  39. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.
    HG Ahuja, Menashe Bar‐Eli, Suresh Hariram Advani, Samuel Benchimol, Martin J. Cline · 1989 · Proceedings of the National Academy of Sciences
  40. Arrangement of chromatin in the nucleus
    D E Comings · 1980 · Human Genetics
  41. The powerful world of antisense oligonucleotides: From bench to bedside
    Anaïs M. Quéméner, Laura Bachelot, Anne Forestier, Emmanuelle Donnou‐Fournet, David Gilot, Marie‐Dominique Galibert · 2020 · Wiley Interdisciplinary Reviews - RNA
  42. Myeloproliferative disorders
    Ross L. Levine, Dwight Gary Gilliland · 2008 · Blood
  43. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi)
    Monika Wilda, Uta Fuchs, Wilhelm Wößmann, Arndt Borkhardt · 2002 · Oncogene
  44. Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated Efflux
    Haiqing Isaac Dai, Peter Marbach, Michel Lemaire, Michael Hayes, William F. Elmquist · 2003 · Journal of Pharmacology and Experimental Therapeutics
  45. Perspectives on the development of a molecularly targeted agent
    Brian J. Druker · 2002 · Cancer Cell
  46. Clustering of aberrations to specific chromosomes in human neoplasms
    Felix Mitelman, Göran Levan · 2009 · Hereditas
  47. BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin
    Matthias Mayerhofer, Peter Valent, Wolfgang R. Sperr, James D. Griffin, Christian Sillaber · 2002 · Blood
  48. Chromosome translocations: dangerous liaisons revisited
    Janet D. Rowley · 2001 · Nature reviews. Cancer
  49. Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a src-dependent fashion
    Marco Mineo, Susan H. Garfield, Simona Taverna, Anna Maria Flugy, Giacomo De Leo, Riccardo Alessandro, Elise C. Kohn · 2011 · Angiogenesis
  50. A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia
    Razelle Kurzrock, Mordechai Shtalrid, Paolo Romero, William S. Kloetzer, Moshe Talpas, José Manuel Trujillo, Mark B. Blick, Miloslav Beran, Jordan U. Gutterman · 1987 · Nature
  51. Somatic rearrangement of chromosome 14 in human lymphocytes.
    Barbara K. Hecht, Frederick Hecht, David G. Harnden, Raymond L. Teplitz · 1975 · Proceedings of the National Academy of Sciences
  52. Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
    Gopinath Sutendra, Evangelos D. Michelakis · 2013 · Frontiers in Oncology
  53. In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents
    Yasuhiko Kano, Miyuki Akutsu, Saburo Tsunoda, Hiroyuki Mano, Yuko Sato, Yoshio Honma, Yusuke Furukawa · 2001 · Blood
  54. MicroRNAs and chromosomal abnormalities in cancer cells
    George Adrian Calin, Carlo Maria Croce · 2006 · Oncogene
  55. The BCR gene encodes a novel serine/threonine kinase activity within a single exon
    Yoshiro Maru, Owen N. Witte · 1991 · Cell
  56. Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration.
    James B. Konopka, Susan M. Watanabe, Jack W. Singer, SJ Collins, Owen N. Witte · 1985 · Proceedings of the National Academy of Sciences
  57. The t(11;14)(p15;q11) in a T-Cell Acute Lymphoblastic Leukemia Cell Line Activates Multiple Transcripts, Including Ttg-1, a Gene Encoding a Potential Zinc Finger Protein
    Elizabeth A. McGuire, Richard D. Hockett, Karen Pollock, Marty F. Bartholdi, Stephen J. O’Brien, Stanley J. Korsmeyer · 1989 · Molecular and Cellular Biology
  58. Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides
    Karl J. Aichberger, Matthias Mayerhofer, Maria‐Theresa Krauth, Hans Skvara, Stefan Florian, Karoline Sonneck, Cahit Akgul, Sophia V. Derdak, Winfried Franz Pickl, Volker Wacheck et al. · 2004 · Blood
  59. New Insights into the Pathophysiology of Chronic Myeloid Leukemia and Imatinib Resistance
    Hagop M. Kantarjian, Moshe Talpaz, Francis Joseph Giles, Susan Mary O'Brien, Jörge E. Cortes · 2006 · Annals of Internal Medicine
  60. Model for the genetic evolution of human solid tumors.
    Stanley E. Shackney, Christina Smith, B W Miller, Dennis R. Burholt, K Murtha, Harlan R. Giles, Deborah M. Ketterer, A A Pollice · 1989 · PubMed
  61. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia
    Brian J.P. Huntly · 2001 · Blood
  62. Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation
    Melissa S. Holtz, Marilyn L. Slovak, Feiyu Zhang, Charles L. Sawyers, Stephen J. Forman, Ravi Bhatia · 2002 · Blood
  63. Genetics, genomics, and cancer risk assessment
    Jeffrey N. Weitzel, Kathleen Reilly Blazer, Deborah J. MacDonald, Julie O. Culver, Kenneth Offit · 2011 · CA A Cancer Journal for Clinicians
  64. Evidence of a New Chimericbcr/c-ablmRNA in Patients with Chronic Myelocytic Leukemia and the Philadelphia Chromosome
    Kees Stam, Nora Heisterkamp, Gerard C. Grosveld, Annelies de Klein, Ram S. Verma, Morton Coleman, Harvey Dosik, John Groffen · 1985 · New England Journal of Medicine
  65. Oncogene addiction as a foundational rationale for targeted anti‐cancer therapy: promises and perils
    Davide Torti, Livio Trusolino · 2011 · EMBO Molecular Medicine
  66. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.
    Catherine M. Verfaillie, James B. McCarthy, Philip B. McGlave · 1992 · Journal of Clinical Investigation
  67. Targeting Akt in cancer for precision therapy
    Hui Ming Hua, Hongying Zhang, Jingzhu Chen, Jiao Wang, Jieya Liu, Yangfu Jiang · 2021 · Journal of Hematology & Oncology
  68. Mechanisms of Primary and Secondary Resistance to Imatinib in Chronic Myeloid Leukemia
    Alfonso Quintás‐Cardama, Hagop M. Kantarjian, Jörge E. Cortes · 2009 · Cancer Control
  69. Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses
    Javier A. Pinilla-Ibarz, Kathleen N. S. Cathcart, Tatyana Korontsvit, Steven L. Soignet, Monica Bocchia, Janine Caggiano, Lawrence T. Lai, Javier López Jiménez, Jonathan E. Kolitz, David A. Scheinberg · 2000 · Blood
  70. Site‐specific reciprocal translocation, t(11;22) (q23;q11), in several unrelated families with 3:1 meiotic disjunction
    Elaine H. Zackai, Beverly S. Emanuel, John M. Optiz · 1980 · American Journal of Medical Genetics
  71. STI571 (Gleevec™) as a paradigm for cancer therapy
    Brian J. Druker · 2002 · Trends in Molecular Medicine
  72. Chronic Myelogenous Leukemia — New Concepts
    Harold Phillip Koeffler, David W. Golde · 1981 · New England Journal of Medicine
  73. The Philadelphia chromosome in leukemogenesis
    Zhi-Jie Kang, Yu-Fei Liu, Ling-Zhi Xu, Zi‐Jie Long, Dan Ai Huang, Ya Yang, Bing Liu, Jiu-Xing Feng, Yu-Jia Pan, Jinsong Yan et al. · 2016 · 癌症：英文版
  74. A Remote GATA2 Hematopoietic Enhancer Drives Leukemogenesis in inv(3)(q21;q26) by Activating EVI1 Expression
    Hiromi Yamazaki, Mikiko Suzuki, Akihito Otsuki, Ritsuko Shimizu, Emery H. Bresnick, James Douglas Engel, Masayuki P. Yamamoto · 2014 · Cancer Cell
  75. Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study
    Martin A. Champagne, Renaud Capdeville, Mark Krailo, Wenchun Qu, Bin Peng, Marianne Rosamilia, Martine Therrien, Ulrike Zoellner, Susan M. Blaney, Mark L. Bernstein · 2004 · Blood
  76. Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring
    Elias Joseph Jabbour, Hagop M. Kantarjian · 2024 · American Journal of Hematology
  77. Expression of a Distinctive BCR-ABL Oncogene in Ph 1 -Positive Acute Lymphocytic Leukemia (ALL)
    Steven S. Clark, Jami McLaughlin, Michael Timmons, Ann Marie Pendergast, Yinon Ben‐Neriah, Lois W. Dow, WM Crist, G Rovera, Stephen D. Smith, Owen N. Witte · 1988 · Science
  78. Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562.
    Steven John Collins, Mark T. Groudine · 1983 · Proceedings of the National Academy of Sciences
  79. Chromosomal Abnormalities in Cancer
    Fröhling, Stefan, Döhner, Hartmut · 2008 · New England Journal of Medicine
  80. Aneuploidy, the somatic mutation that makes cancer a species of its own
    PETER H. DUESBERG, David Rasnick · 2000 · Cell Motility and the Cytoskeleton
  81. The crucial role of multiomic approach in cancer research and clinically relevant outcomes
    Miaolong Lu, Xianquan Zhan · 2018 · The EPMA Journal
  82. Clinical Implications of the Cancer Genome
    Laura E. MacConaill, Levi A. Garraway · 2010 · Journal of Clinical Oncology
  83. Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia
    Herrmann, Harald, Sadovnik, Irina, Cerny-Reiterer, Sabine, Rülicke, Thomas, Stefanzl, Gabriele, Willmann, Michael, Hoermann, Gregor, Bilban, Martin, Blatt, Katharina, Herndlhofer, Susanne et al. · 2014 · Blood
  84. The role of STATs in myeloid differentiation and leukemia
    Paul James Coffer, Leo Koenderman, Rolf P. de Groot · 2000 · Oncogene
  85. Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans – man and his best friend share more than companionship
    Matthew Breen, Jaime F. Modiano · 2008 · Chromosome Research
  86. Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy
    Simona Soverini, Manuela Mancini, Luana Bavaro, Michèle Cavo, Giovanni Martinelli · 2018 · Molecular Cancer
  87. Chromosome segregation errors generate a diverse spectrum of simple and complex genomic rearrangements
    Peter Ly, Simon F. Brunner, Ofer Shoshani, Dong Hyun Kim, Weijie Lan, Tatyana Pyntikova, Adrienne Margaret Flanagan, Sam Behjati, David C. Page, Peter J. Campbell et al. · 2019 · Nature Genetics
  88. p53 in chronic myelogenous leukemia in acute phase.
    Elena Feinstein, Giuseppe G. Cimino, Gale Rp, G. Alimena, R Berthier, K Kishi, John M. Goldman, Alfonso Zaccaria, Alan Berrebi, Eli Canaani · 1991 · Proceedings of the National Academy of Sciences
  89. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis
    Steffen Koschmieder, Berthold Göttgens, Pu Zhang, Junko Iwasaki-Arai, Koichi Akashi, Jeffery Lorne Kutok, Tajhal Dayaram, Kristin Geary, Anthony Richard Green, Daniel Geoffrey Tenen et al. · 2004 · Blood
  90. A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance
    Kiranmai Gumireddy, Stacey J. Baker, Stephen C. Cosenza, Premila John, Anthony D. Kang, Kimberly A. Robell, M. V. Ramana Reddy, E. Premkumar Reddy · 2005 · Proceedings of the National Academy of Sciences
  91. BCR/ABL Regulates Expression of the Cyclin-dependent Kinase Inhibitor p27Kip1 through the Phosphatidylinositol 3-Kinase/AKT Pathway
    Franck Gesbert, William R. Sellers, Sabina Signoretti, Massimo F. Loda, James D. Griffin · 2000 · Journal of Biological Chemistry
  92. Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells
    Xin Mao, Chun Rong Yu, Wen Hua Li, Wenxin Li · 2008 · Cell Research
  93. The Molecular Basis of Leukemia
    Franklin H. Epstein, Martin J. Cline · 1994 · New England Journal of Medicine
  94. Chromosomal alterations in squamous cell carcinomas of the head and neck: Window to the biology of disease
    Susanne M. Gollin · 2001 · Head & Neck
  95. Chronic Myeloid Leukemia: Diagnosis and Treatment
    Alfonso Quintás‐Cardama, Jörge E. Cortes · 2006 · Mayo Clinic Proceedings
  96. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia
    Christine J. Harrison · 2008 · British Journal of Haematology
  97. Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias
    Neil P. Shah, Charles L. Sawyers · 2003 · Oncogene
  98. The coming decade in precision oncology: six riddles
    Adam Wahida, Lars Buschhorn, Stefan Fröhling, Philipp Jakob Jost, Andreas Schneeweiß, Peter Lichter, Razelle Kurzrock · 2022 · Nature reviews. Cancer
  99. The molecular biology of chronic myeloid leukaemia.
    Junia V. Melo · 1996 · PubMed
  100. BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice
    JW Voncken, Vesa Kaartinen, P K Pattengale, Wilfred T.V. Germeraad, John Groffen, Nora Heisterkamp · 1995 · Blood